For these reasons, we confirmed the activation of TGF-β in vivo in mammary tumors generated in the GEMM of metastatic Prune-1-driven TNBC (i.e., MMTV–Prune-1/Wnt1 cells; Figure S6A). This evidence concerns the gene WNT1 and breast cancer.